Dermatitis Medical Pharmaceutical 
The Dermatology Digest
JANUARY 21, 2025
Dupilumab (Dupixent, Sanofi & Regeneron) may boost height in kids with severe atopic dermatitis (AD), according to a late-breaking abstract presented at Maui Derm Hawaii 2025. Cyr, PhD, Senior Director of Medical Affairs at Regeneron Pharmaceuticals, received the best poster Akamai Award at the meeting.
The Dermatology Digest
DECEMBER 30, 2024
More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.
The Dermatology Digest
FEBRUARY 26, 2024
Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the biologics).
The Dermatology Digest
MARCH 11, 2024
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.
The Dermatology Digest
OCTOBER 26, 2024
Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. The most frequently reported TEAEs included nasopharyngitis, acne, upper respiratory tract infection, and atopic dermatitis.
First Derm
FEBRUARY 21, 2024
There’s a crucial difference between cosmetic retinol use and medical treatment with retinoids ; the latter is for specific skin conditions under professional supervision. These medical-grade retinoids are often available only by prescription and are used under the close supervision of a healthcare provider.
The Dermatology Digest
MARCH 10, 2024
Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, discusses which ones works best.
Expert insights. Personalized for you.
74 
Let's personalize your content